We're looking for a passionate, growth-oriented, and strategically minded Clinical Strategy Director to join our Tokyo-based clinical development team. You will lead the development and execution of clinical development strategy in Japan for assigned products, working with internal and external stakeholders on regulatory interactions, submission documents, and external expert networks.
About the Team
You'll work closely with colleagues across Clinical Development, Medical Affairs, Regulatory Affairs, Pharmacovigilance, and Marketing to drive clinical development strategy in Japan — and with Global Asset Teams to ensure Japan's perspective is reflected in global development plans.
Key Responsibilities
Lead the development and execution of clinical development plans in Japan
Manage regulatory authority interactions and support submission documentation
Build and maintain relationships with external experts and key opinion leaders
Oversee trial design, conduct, evaluation, and reporting
Communicate clinical strategy to internal and external stakeholders
Contribute clinical input to regulatory submissions, approvals, and launches
Input into global trial design — including pediatric development planning — to ensure Japanese patient populations are represented
What You'll Bring
Medical degree (MD) required
5+ years of clinical development experience in the pharmaceutical industry
Experience interacting with regulatory authorities and preparing submission documentation
Japanese native, or business level; English proficiency sufficient for daily basic conversations
Leadership experience in a matrix organization
Why This Role
Real authority to negotiate directly with Japan's regulator on pediatric development plans and whether local bridging studies are even required — not just executing a playbook set elsewhere
A genuinely two-way strategic role: shaping global trial design around Japan's patient population, not just running the Japan leg of someone else's plan
Exposure to a specialty pipeline actively expanding into new populations and modalities